AUTHORS: Kifle, Fitsum MSc et al Anesthesia & Analgesia: May 2022 – Volume 134 – Issue 5 – p 930-937 BACKGROUND: The burden of critical illness in low-income countries is high and expected to rise. This has implications for wider public health measures including maternal mortality, deaths from communicable diseases, and the global burden of disease […]
Read MoreAUTHORS: Ruetzler, Kurt MD, FAHA et al Anesthesia & Analgesia: May 2022 – Volume 134 – Issue 5 – p 1043-1053 BACKGROUND: Sugammadex and neostigmine given to reverse residual neuromuscular blockade can cause side effects including bradycardia, anaphylaxis, bronchospasm, and even cardiac arrest. We tested the hypothesis that sugammadex is noninferior to neostigmine on a composite […]
Read MoreAUTHORS: Zhao, Hong MD et al Anesthesia & Analgesia: May 2022 – Volume 134 – Issue 5 – p 1035-1042 BACKGROUND: Hip fracture is a serious event in the older population and is associated with morbidity, mortality, and disability among those who survive. Emerging evidence suggests that frailty is pertinent to the clinical outcomes of older […]
Read MoreAUTHORS: Park, Seoyeong MD et al Anesthesia & Analgesia: May 2022 – Volume 134 – Issue 5 – p 1021-1027 BACKGROUND: The fibrinogen-to-albumin ratio (FAR) is a recently introduced prognostic marker for patients with coronary artery disease. The present study investigated whether the FAR is associated with clinical outcome after off-pump coronary artery bypass grafting (OPCAB). […]
Read MoreAUTHORS: Elmofty, Dalia H. MD Anesthesia & Analgesia: May 2022 – Volume 134 – Issue 5 – p 1028-1034 BACKGROUND: Venous thromboembolism (VTE) is a leading cause of maternal morbidity and mortality in the United States. Subcutanous unfractionated heparin (UFH) has been used for decades for VTE prophylaxis and under many obstetric quality of care initiatives, […]
Read More